Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Kaixuan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0006-2221-8256; OpenAlex author ID A5104909261. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 3, last author 3)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
47
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper, 1 trial · 2025: 1 paper

Papers 13

  1. THBS1 knockdown suppresses pancreatic cancer progression through JAK2/STAT3 signaling pathway. First author DOI 10.1016/j.mcp.2024.102003↗
  2. Clinical efficacy of EUS-guided celiac plexus neurolysis versus EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain relief in advanced pancre… Last author DOI 10.1097/eus.0000000000000048↗
  3. Nursing Cooperation Pattern for Patients With Advanced Pancreatic Cancer and Abdominal Pain Undergoing Endoscopic Ultrasound-guided Celiac Plexus Neurolysis. Co-author PMID 36239570↗
  4. Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.652283↗
  5. A novel lncRNA PTTG3P/miR-132/212-3p/FoxM1 feedback loop facilitates tumorigenesis and metastasis of pancreatic cancer. Last author DOI 10.1038/s41420-020-00360-5↗
  6. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: stu… Co-author DOI 10.1186/s13014-019-1254-8↗
  7. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer. First author DOI 10.3892/or.2018.6761↗
  8. HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. Co-author PMID 31949740↗
  9. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression. Co-author DOI 10.1186/1756-9966-32-86↗
  10. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus. Co-author DOI 10.1002/dmrr.1284↗
  11. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China. Co-author DOI 10.1097/mpa.0b013e31822ca176↗
  12. Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. First author DOI 10.1002/ijc.25426↗
  13. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Last author DOI 10.1016/j.ejca.2010.07.010↗

Trials 1

  1. Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer Principal investigator NCT04536220↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ping Li · 1 shared paper, 2025 · strength 0.30
  2. Zhaowei Chen · 1 shared paper, 2025 · strength 0.30
  3. Jun Gao · 4 shared papers, 2012–2021 · strength 0.26
  4. Xiangyu Kong · 2 shared papers, 2020–2021 · strength 0.23
  5. Pingping Zhang · 1 shared paper, 2024 · strength 0.22
  6. Jun Yao · 1 shared paper, 2023 · strength 0.18
  7. Tingting Liu · 1 shared paper, 2023 · strength 0.18
  8. Defeng Li · 1 shared paper, 2023 · strength 0.18
  9. Lisheng Wang · 1 shared paper, 2023 · strength 0.18
  10. Qiwen Ben · 4 shared papers, 2011–2012 · strength 0.13
  11. Yaozong Yuan · 4 shared papers, 2011–2012 · strength 0.13
  12. Yuqiong Wang · 1 shared paper, 2021 · strength 0.12
  13. Hongyu Wu · 1 shared paper, 2021 · strength 0.12
  14. Hongwei Xu · 1 shared paper, 2021 · strength 0.12
  15. Wenyu Liu · 1 shared paper, 2020 · strength 0.11
  16. Zhaoshen Li · 1 shared paper, 2020 · strength 0.11
  17. Huiqing Zhang · 1 shared paper, 2020 · strength 0.11
  18. Huiyun Zhu · 1 shared paper, 2020 · strength 0.11
  19. Fanyang Kong · 1 shared paper, 2020 · strength 0.11
  20. Zhaoshen Li · 3 shared papers, 2011–2012 · strength 0.09
  21. Suizhi Gao · 1 shared paper, 2019 · strength 0.09
  22. Yun Bian · 1 shared paper, 2019 · strength 0.09
  23. Kai Cao · 1 shared paper, 2019 · strength 0.09
  24. Shiwei Guo · 1 shared paper, 2019 · strength 0.09
  25. Hui Jiang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.